Pfizer Inc and partner BioNTech SE said on Friday they had applied to the European health regulator to extend the marketing authorization for their coronavirus vaccine for use in adolescents aged 12 to 15.
The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
US Centers for Disease Control and Prevention director Rochelle Walensky told ABC News earlier this month that she expected the vaccine to be authorized for 12- to 15-year-olds by mid-May.
The actor attended the event in the UAE along with his family
Tremors were felt in the Greek capital of Athens and as far away as the southern island of Crete
The Buyback Programme is a huge step in creating solutions for nature
Dozens of other products that contain benikoji — including miso paste, crackers and a vinegar dressing — have been withdrawn from the market
The passengers were on a trip to an Easter weekend church gathering
Pavel Durov said measures were taken immediately to stop 'a flurry of unknown users posting messages appearing to call for violence'
Motorists have been advised to drive carefully and abide by traffic rules and regulations